Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEYOND: Betaseron 250 vs 500 mcg vs Copaxone in RRMS
NCT00099502Phase 3Completed
- Sponsor
- Bayer
- Start
- Nov 2003
- Modality
- Cytokines & Interferons
- Countries
- 26
01
Overview
A Phase 3 trial of interferon beta-1b in relapsing-remitting multiple sclerosis (RRMS), sponsored by Bayer. Started Nov 2003; status: completed.
02
Drugs
interferon beta-1b
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00099502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00099502.